Baird raises Regeneron Pharmaceuticals' target price to $875 from $761
REGN•Baird raised its target price for Regeneron Pharmaceuticals to $875 from $761.
Related News
Tenet Healthcare target price raised to $304 from $283
THC•
Lazard expects Lazard CL to generate about $500 million in revenue in 2027
LAZ•
Colgate-Palmolive target price raised to $101 from $95
CL•
Builders FirstSource: Stephens raises target price to $65 from $57
BLDR•
Knife River Corp: Stephens cuts target price to $65 from $80
KNF•